The field of medical devices is rapidly evolving, and as technological advancements continue, so do the regulatory frameworks governing their approval and marketing.
The time has finally come: almost 1.5 years after the MDR came into force, the MDCG has published the long-awaited
guidance document for the preparation of the PSUR.
In China, Post Market Surveillance (PMS) is an important component of the regulation for medical devices, ensuring the safety and effectiveness of these products.